APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Anti-Tuberculosis Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Anti-Tuberculosis Drug Industry Growth and Trends Forecast to 2032

Report ID 173965470131 December 202598 pages

Choose your research edition.

Industry ResearchAnti-Tuberculosis Drug Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-Tuberculosis Drug Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Anti-Tuberculosis Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-Tuberculosis Drug Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-Tuberculosis Drug Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Anti-Tuberculosis Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Anti-Tuberculosis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Anti-Tuberculosis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anti-Tuberculosis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Anti-Tuberculosis Drug include Abbott, Sanofi, NOVARTIS, Prizer, Otsuka and Lupin, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Anti-Tuberculosis Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Anti-Tuberculosis Drug market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Anti-Tuberculosis Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Anti-Tuberculosis Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Anti-Tuberculosis Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Anti-Tuberculosis Drug Market by Company

Abbott

Sanofi

NOVARTIS

Prizer

Otsuka

Lupin

Anti-Tuberculosis Drug Segment by Type

First-Line Anti-Tuberculosis Drugs

Second-Line Anti-Tuberculosis Drugs

Anti-Tuberculosis Drug Segment by Application

Hospital

Clinic

Others

Anti-Tuberculosis Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-Tuberculosis Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-Tuberculosis Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-Tuberculosis Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Anti-Tuberculosis Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Anti-Tuberculosis Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of First-Line Anti-Tuberculosis Drugs Table 2. Major Company of Second-Line Anti-Tuberculosis Drugs Table 3. Global Anti-Tuberculosis Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Anti-Tuberculosis Drug Sales by Type (2021-2026) & (K Units) Table 5. Global Anti-Tuberculosis Drug Sales Market Share in Volume by Type (2021-2026) Table 6. Global Anti-Tuberculosis Drug Sales by Type (2021-2026) & (US$ Million) Table 7. Global Anti-Tuberculosis Drug Sales Market Share in Value by Type (2021-2026) Table 8. Global Anti-Tuberculosis Drug Price by Type (2021-2026) & (US$/Unit) Table 9. Global Anti-Tuberculosis Drug Sales by Type (2027-2032) & (K Units) Table 10. Global Anti-Tuberculosis Drug Sales Market Share in Volume by Type (2027-2032) Table 11. Global Anti-Tuberculosis Drug Sales by Type (2027-2032) & (US$ Million) Table 12. Global Anti-Tuberculosis Drug Sales Market Share in Value by Type (2027-2032) Table 13. Global Anti-Tuberculosis Drug Price by Type (2027-2032) & (US$/Unit) Table 14. North America Anti-Tuberculosis Drug Sales by Type (2021-2026) & (K Units) Table 15. North America Anti-Tuberculosis Drug Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Anti-Tuberculosis Drug Sales by Type (2021-2026) & (K Units) Table 17. Europe Anti-Tuberculosis Drug Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Anti-Tuberculosis Drug Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Anti-Tuberculosis Drug Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Anti-Tuberculosis Drug Sales by Type (2021-2026) & (K Units) Table 21. Latin America Anti-Tuberculosis Drug Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Anti-Tuberculosis Drug Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Anti-Tuberculosis Drug Sales by Type (2021-2026) & (US$ Million) Table 24. Anti-Tuberculosis Drug Industry Trends Table 25. Anti-Tuberculosis Drug Industry Drivers Table 26. Anti-Tuberculosis Drug Industry Opportunities and Challenges Table 27. Anti-Tuberculosis Drug Industry Restraints Table 28. Global Anti-Tuberculosis Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Anti-Tuberculosis Drug Revenue Market Share by Company (2021-2026) Table 30. Global Anti-Tuberculosis Drug Sales by Company (2021-2026) & (K Units) Table 31. Global Anti-Tuberculosis Drug Sales Share by Company (2021-2026) Table 32. Global Anti-Tuberculosis Drug Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Anti-Tuberculosis Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Anti-Tuberculosis Drug Major Company Production Sites and Headquarters Table 35. Global Anti-Tuberculosis Drug Company, Product Type & Application Table 36. Global Anti-Tuberculosis Drug Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Anti-Tuberculosis Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Anti-Tuberculosis Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Anti-Tuberculosis Drug Sales by Region (2021-2026) & (K Units) Table 41. Global Anti-Tuberculosis Drug Sales Market Share in Volume by Region (2021-2026) Table 42. Global Anti-Tuberculosis Drug Sales by Region (2021-2026) & (US$ Million) Table 43. Global Anti-Tuberculosis Drug Sales Market Share in Value by Region (2021-2026) Table 44. Global Anti-Tuberculosis Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Anti-Tuberculosis Drug Sales by Region (2027-2032) & (K Units) Table 46. Global Anti-Tuberculosis Drug Sales Market Share in Volume by Region (2027-2032) Table 47. Global Anti-Tuberculosis Drug Sales by Region (2027-2032) & (US$ Million) Table 48. Global Anti-Tuberculosis Drug Sales Market Share in Value by Region (2027-2032) Table 49. Global Anti-Tuberculosis Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Anti-Tuberculosis Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Anti-Tuberculosis Drug Sales by Application (2021-2026) & (K Units) Table 52. Global Anti-Tuberculosis Drug Sales Market Share in Volume by Application (2021-2026) Table 53. Global Anti-Tuberculosis Drug Sales by Application (2021-2026) & (US$ Million) Table 54. Global Anti-Tuberculosis Drug Sales Market Share in Value by Application (2021-2026) Table 55. Global Anti-Tuberculosis Drug Price by Application (2021-2026) & (US$/Unit) Table 56. Global Anti-Tuberculosis Drug Sales by Application (2027-2032) & (K Units) Table 57. Global Anti-Tuberculosis Drug Sales Market Share in Volume by Application (2027-2032) Table 58. Global Anti-Tuberculosis Drug Sales by Application (2027-2032) & (US$ Million) Table 59. Global Anti-Tuberculosis Drug Sales Market Share in Value by Application (2027-2032) Table 60. Global Anti-Tuberculosis Drug Price by Application (2027-2032) & (US$/Unit) Table 61. North America Anti-Tuberculosis Drug Sales by Application (2021-2026) & (K Units) Table 62. North America Anti-Tuberculosis Drug Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Anti-Tuberculosis Drug Sales by Application (2021-2026) & (K Units) Table 64. Europe Anti-Tuberculosis Drug Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Anti-Tuberculosis Drug Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Anti-Tuberculosis Drug Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Anti-Tuberculosis Drug Sales by Application (2021-2026) & (K Units) Table 68. Latin America Anti-Tuberculosis Drug Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Anti-Tuberculosis Drug Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Anti-Tuberculosis Drug Sales by Application (2021-2026) & (US$ Million) Table 71. Abbott Company Information Table 72. Abbott Business Overview Table 73. Abbott Anti-Tuberculosis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Abbott Anti-Tuberculosis Drug Product Portfolio Table 75. Abbott Recent Development Table 76. Sanofi Company Information Table 77. Sanofi Business Overview Table 78. Sanofi Anti-Tuberculosis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Sanofi Anti-Tuberculosis Drug Product Portfolio Table 80. Sanofi Recent Development Table 81. NOVARTIS Company Information Table 82. NOVARTIS Business Overview Table 83. NOVARTIS Anti-Tuberculosis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. NOVARTIS Anti-Tuberculosis Drug Product Portfolio Table 85. NOVARTIS Recent Development Table 86. Prizer Company Information Table 87. Prizer Business Overview Table 88. Prizer Anti-Tuberculosis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Prizer Anti-Tuberculosis Drug Product Portfolio Table 90. Prizer Recent Development Table 91. Otsuka Company Information Table 92. Otsuka Business Overview Table 93. Otsuka Anti-Tuberculosis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Otsuka Anti-Tuberculosis Drug Product Portfolio Table 95. Otsuka Recent Development Table 96. Lupin Company Information Table 97. Lupin Business Overview Table 98. Lupin Anti-Tuberculosis Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Lupin Anti-Tuberculosis Drug Product Portfolio Table 100. Lupin Recent Development Table 101. North America Anti-Tuberculosis Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 102. North America Anti-Tuberculosis Drug Sales by Country (2021-2026) & (K Units) Table 103. North America Anti-Tuberculosis Drug Sales Market Share by Country (2021-2026) Table 104. North America Anti-Tuberculosis Drug Sales Forecast by Country (2027-2032) & (K Units) Table 105. North America Anti-Tuberculosis Drug Sales Market Share Forecast by Country (2027-2032) Table 106. North America Anti-Tuberculosis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. North America Anti-Tuberculosis Drug Market Size by Country (2021-2026) & (US$ Million) Table 108. North America Anti-Tuberculosis Drug Market Share by Country (2021-2026) Table 109. North America Anti-Tuberculosis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. North America Anti-Tuberculosis Drug Market Share Forecast by Country (2027-2032) Table 111. Europe Anti-Tuberculosis Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 112. Europe Anti-Tuberculosis Drug Sales by Country (2021-2026) & (K Units) Table 113. Europe Anti-Tuberculosis Drug Sales Market Share by Country (2021-2026) Table 114. Europe Anti-Tuberculosis Drug Sales Forecast by Country (2027-2032) & (K Units) Table 115. Europe Anti-Tuberculosis Drug Sales Market Share Forecast by Country (2027-2032) Table 116. Europe Anti-Tuberculosis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Europe Anti-Tuberculosis Drug Market Size by Country (2021-2026) & (US$ Million) Table 118. Europe Anti-Tuberculosis Drug Market Share by Country (2021-2026) Table 119. Europe Anti-Tuberculosis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Europe Anti-Tuberculosis Drug Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Anti-Tuberculosis Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Anti-Tuberculosis Drug Sales by Country (2021-2026) & (K Units) Table 123. Asia-Pacific Anti-Tuberculosis Drug Sales Market Share by Country (2021-2026) Table 124. Asia-Pacific Anti-Tuberculosis Drug Sales Forecast by Country (2027-2032) & (K Units) Table 125. Asia-Pacific Anti-Tuberculosis Drug Sales Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Anti-Tuberculosis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Anti-Tuberculosis Drug Market Size by Country (2021-2026) & (US$ Million) Table 128. Asia-Pacific Anti-Tuberculosis Drug Market Share by Country (2021-2026) Table 129. Asia-Pacific Anti-Tuberculosis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Asia-Pacific Anti-Tuberculosis Drug Market Share Forecast by Country (2027-2032) Table 131. Latin America Anti-Tuberculosis Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Latin America Anti-Tuberculosis Drug Sales by Country (2021-2026) & (K Units) Table 133. Latin America Anti-Tuberculosis Drug Sales Market Share by Country (2021-2026) Table 134. Latin America Anti-Tuberculosis Drug Sales Forecast by Country (2027-2032) & (K Units) Table 135. Latin America Anti-Tuberculosis Drug Sales Market Share Forecast by Country (2027-2032) Table 136. Latin America Anti-Tuberculosis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Latin America Anti-Tuberculosis Drug Market Size by Country (2021-2026) & (US$ Million) Table 138. Latin America Anti-Tuberculosis Drug Market Share by Country (2021-2026) Table 139. Latin America Anti-Tuberculosis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Latin America Anti-Tuberculosis Drug Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Anti-Tuberculosis Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Anti-Tuberculosis Drug Sales by Country (2021-2026) & (K Units) Table 143. Middle East and Africa Anti-Tuberculosis Drug Sales Market Share by Country (2021-2026) Table 144. Middle East and Africa Anti-Tuberculosis Drug Sales Forecast by Country (2027-2032) & (K Units) Table 145. Middle East and Africa Anti-Tuberculosis Drug Sales Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Anti-Tuberculosis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Anti-Tuberculosis Drug Market Size by Country (2021-2026) & (US$ Million) Table 148. Middle East and Africa Anti-Tuberculosis Drug Market Share by Country (2021-2026) Table 149. Middle East and Africa Anti-Tuberculosis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Middle East and Africa Anti-Tuberculosis Drug Market Share Forecast by Country (2027-2032) Table 151. Key Raw Materials Table 152. Raw Materials Key Suppliers Table 153. Anti-Tuberculosis Drug Distributors List Table 154. Anti-Tuberculosis Drug Customers List Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Anti-Tuberculosis Drug Image Figure 2. Global Anti-Tuberculosis Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anti-Tuberculosis Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Anti-Tuberculosis Drug Sales (2021-2032) & (K Units) Figure 5. First-Line Anti-Tuberculosis Drugs Image Figure 6. Global First-Line Anti-Tuberculosis Drugs Sales YoY Growth (2021-2032) & (K Units) Figure 7. Second-Line Anti-Tuberculosis Drugs Image Figure 8. Global Second-Line Anti-Tuberculosis Drugs Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Anti-Tuberculosis Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Anti-Tuberculosis Drug Market Share by Type 2025 VS 2032 Figure 11. North America Anti-Tuberculosis Drug Sales Market Share in Volume by Type in 2025 Figure 12. North America Anti-Tuberculosis Drug Sales Market Share in Value by Type in 2025 Figure 13. Europe Anti-Tuberculosis Drug Sales Market Share in Volume by Type in 2025 Figure 14. Europe Anti-Tuberculosis Drug Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Anti-Tuberculosis Drug Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Anti-Tuberculosis Drug Sales Market Share in Value by Type in 2025 Figure 17. Latin America Anti-Tuberculosis Drug Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Anti-Tuberculosis Drug Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Anti-Tuberculosis Drug Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Anti-Tuberculosis Drug Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Anti-Tuberculosis Drug Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Anti-Tuberculosis Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Anti-Tuberculosis Drug Market Share by Application 2025 VS 2032 Figure 31. North America Anti-Tuberculosis Drug Sales Market Share in Volume by Application in 2025 Figure 32. North America Anti-Tuberculosis Drug Sales Market Share in Value by Application in 2025 Figure 33. Europe Anti-Tuberculosis Drug Sales Market Share in Volume by Application in 2025 Figure 34. Europe Anti-Tuberculosis Drug Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Anti-Tuberculosis Drug Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Anti-Tuberculosis Drug Sales Market Share in Value by Application in 2025 Figure 37. Latin America Anti-Tuberculosis Drug Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Anti-Tuberculosis Drug Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Anti-Tuberculosis Drug Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Anti-Tuberculosis Drug Sales Market Share in Value by Application in 2025 Figure 41. North America Anti-Tuberculosis Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Anti-Tuberculosis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Anti-Tuberculosis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Anti-Tuberculosis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Anti-Tuberculosis Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Anti-Tuberculosis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Anti-Tuberculosis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Anti-Tuberculosis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Anti-Tuberculosis Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Anti-Tuberculosis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Anti-Tuberculosis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Anti-Tuberculosis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Anti-Tuberculosis Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Anti-Tuberculosis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Anti-Tuberculosis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Anti-Tuberculosis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Anti-Tuberculosis Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Anti-Tuberculosis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Anti-Tuberculosis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Anti-Tuberculosis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Anti-Tuberculosis Drug Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Anti-Tuberculosis Drug Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • First-Line Anti-Tuberculosis Drugs
  • Second-Line Anti-Tuberculosis Drugs
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Abbott
  • Sanofi
  • NOVARTIS
  • Prizer
  • Otsuka
  • Lupin

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Anti-Tuberculosis Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Anti-Tuberculosis Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Anti-Tuberculosis Drug Market by Type
  6. 1.3.1 First-Line Anti-Tuberculosis Drugs
  7. 1.3.2 Second-Line Anti-Tuberculosis Drugs
  8. 1.4 Global Anti-Tuberculosis Drug Market Size by Type
  9. 1.4.1 Global Anti-Tuberculosis Drug Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Anti-Tuberculosis Drug Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Anti-Tuberculosis Drug Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Anti-Tuberculosis Drug Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Anti-Tuberculosis Drug Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Anti-Tuberculosis Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Anti-Tuberculosis Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Anti-Tuberculosis Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Anti-Tuberculosis Drug Industry Trends
  2. 2.2 Anti-Tuberculosis Drug Industry Drivers
  3. 2.3 Anti-Tuberculosis Drug Industry Opportunities and Challenges
  4. 2.4 Anti-Tuberculosis Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Anti-Tuberculosis Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Anti-Tuberculosis Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Anti-Tuberculosis Drug Price (2021-2026)
  4. 3.4 Global Anti-Tuberculosis Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Anti-Tuberculosis Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Anti-Tuberculosis Drug Company, Product Type & Application
  7. 3.7 Global Anti-Tuberculosis Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Anti-Tuberculosis Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Anti-Tuberculosis Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Anti-Tuberculosis Drug Tier 1, Tier 2, and Tier 3
4 Anti-Tuberculosis Drug Regional Status and Outlook
  1. 4.1 Global Anti-Tuberculosis Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Anti-Tuberculosis Drug Historic Market Size by Region
  3. 4.2.1 Global Anti-Tuberculosis Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Anti-Tuberculosis Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Anti-Tuberculosis Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Anti-Tuberculosis Drug Forecasted Market Size by Region
  7. 4.3.1 Global Anti-Tuberculosis Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Anti-Tuberculosis Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Anti-Tuberculosis Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Anti-Tuberculosis Drug by Application
  1. 5.1 Anti-Tuberculosis Drug Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Anti-Tuberculosis Drug Market Size by Application
  6. 5.2.1 Global Anti-Tuberculosis Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Anti-Tuberculosis Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Anti-Tuberculosis Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Anti-Tuberculosis Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Anti-Tuberculosis Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Anti-Tuberculosis Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Anti-Tuberculosis Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Anti-Tuberculosis Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Abbott
  2. 6.1.1 Abbott Company Information
  3. 6.1.2 Abbott Business Overview
  4. 6.1.3 Abbott Anti-Tuberculosis Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Abbott Anti-Tuberculosis Drug Product Portfolio
  6. 6.1.5 Abbott Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi Anti-Tuberculosis Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi Anti-Tuberculosis Drug Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 NOVARTIS
  14. 6.3.1 NOVARTIS Company Information
  15. 6.3.2 NOVARTIS Business Overview
  16. 6.3.3 NOVARTIS Anti-Tuberculosis Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 NOVARTIS Anti-Tuberculosis Drug Product Portfolio
  18. 6.3.5 NOVARTIS Recent Developments
  19. 6.4 Prizer
  20. 6.4.1 Prizer Company Information
  21. 6.4.2 Prizer Business Overview
  22. 6.4.3 Prizer Anti-Tuberculosis Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Prizer Anti-Tuberculosis Drug Product Portfolio
  24. 6.4.5 Prizer Recent Developments
  25. 6.5 Otsuka
  26. 6.5.1 Otsuka Company Information
  27. 6.5.2 Otsuka Business Overview
  28. 6.5.3 Otsuka Anti-Tuberculosis Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Otsuka Anti-Tuberculosis Drug Product Portfolio
  30. 6.5.5 Otsuka Recent Developments
  31. 6.6 Lupin
  32. 6.6.1 Lupin Company Information
  33. 6.6.2 Lupin Business Overview
  34. 6.6.3 Lupin Anti-Tuberculosis Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Lupin Anti-Tuberculosis Drug Product Portfolio
  36. 6.6.5 Lupin Recent Developments
7 North America by Country
  1. 7.1 North America Anti-Tuberculosis Drug Sales by Country
  2. 7.1.1 North America Anti-Tuberculosis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Anti-Tuberculosis Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Anti-Tuberculosis Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Anti-Tuberculosis Drug Market Size by Country
  6. 7.2.1 North America Anti-Tuberculosis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Anti-Tuberculosis Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Anti-Tuberculosis Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Anti-Tuberculosis Drug Sales by Country
  2. 8.1.1 Europe Anti-Tuberculosis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Anti-Tuberculosis Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Anti-Tuberculosis Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Anti-Tuberculosis Drug Market Size by Country
  6. 8.2.1 Europe Anti-Tuberculosis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Anti-Tuberculosis Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Anti-Tuberculosis Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Anti-Tuberculosis Drug Sales by Country
  2. 9.1.1 Asia-Pacific Anti-Tuberculosis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Anti-Tuberculosis Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Anti-Tuberculosis Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Anti-Tuberculosis Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Anti-Tuberculosis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Anti-Tuberculosis Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Anti-Tuberculosis Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Anti-Tuberculosis Drug Sales by Country
  2. 10.1.1 South America Anti-Tuberculosis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Anti-Tuberculosis Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Anti-Tuberculosis Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Anti-Tuberculosis Drug Market Size by Country
  6. 10.2.1 South America Anti-Tuberculosis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Anti-Tuberculosis Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Anti-Tuberculosis Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Anti-Tuberculosis Drug Sales by Country
  2. 11.1.1 Middle East and Africa Anti-Tuberculosis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Anti-Tuberculosis Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Anti-Tuberculosis Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Anti-Tuberculosis Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Anti-Tuberculosis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Anti-Tuberculosis Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Anti-Tuberculosis Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Anti-Tuberculosis Drug Value Chain Analysis
  2. 12.1.1 Anti-Tuberculosis Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Anti-Tuberculosis Drug Production Mode & Process
  7. 12.2 Anti-Tuberculosis Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Anti-Tuberculosis Drug Distributors
  10. 12.2.3 Anti-Tuberculosis Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst